Although a direct relationship between serum cholesterol parameters and incidence of hormonally driven cancer is still missing, we assessed whether PCSK9 levels correlates with changes in lipids and found that PCSK9 was positively correlated with an atherogenic pattern (i.e., LDL-C, non-HDL-C, and remnant cholesterol). The gene discussed is PCSK9; the disease is cancer.